Publicaciones en colaboración con investigadores/as de Universidad Miguel Hernández de Elche (10)

2019

  1. Cationic niosomes as non-viral vehicles for nucleic acids: Challenges and opportunities in gene delivery

    Pharmaceutics, Vol. 11, Núm. 2

  2. Non-viral vectors based on cationic niosomes and minicircle DNA technology enhance gene delivery efficiency for biomedical applications in retinal disorders

    Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 17, pp. 308-318

2018

  1. Polysorbate 20 non-ionic surfactant enhances retinal gene delivery efficiency of cationic niosomes after intravitreal and subretinal administration

    International Journal of Pharmaceutics, Vol. 550, Núm. 1-2, pp. 388-397

2017

  1. Non-viral vectors based on magnetoplexes, lipoplexes and polyplexes for VEGF gene delivery into central nervous system cells

    International Journal of Pharmaceutics, Vol. 521, Núm. 1-2, pp. 130-140

2016

  1. The influence of the polar head-group of synthetic cationic lipids on the transfection efficiency mediated by niosomes in rat retina and brain

    Biomaterials, Vol. 77, pp. 267-279

2015

  1. Niosomes based on synthetic cationic lipids for gene delivery: The influence of polar head-groups on the transfection efficiency in HEK-293, ARPE-19 and MSC-D1 cells

    Organic and Biomolecular Chemistry, Vol. 13, Núm. 4, pp. 1068-1081

  2. Protamine/DNA/niosome ternary nonviral vectors for gene delivery to the retina: The role of protamine

    Molecular Pharmaceutics, Vol. 12, Núm. 10, pp. 3658-3671

2014

  1. A novel cationic niosome formulation for gene delivery to the retina

    Journal of Controlled Release, Vol. 174, Núm. 1, pp. 27-36

2013

  1. Low molecular weight oligochitosans for non-viral retinal gene therapy

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 83, Núm. 2, pp. 131-140

  2. Oligochitosan polyplexes as carriers for retinal gene delivery

    European Journal of Pharmaceutical Sciences, Vol. 48, Núm. 1-2, pp. 323-331